CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis

Area of Science:

• Immunogenetics
• Rheumatology

Background:

• Rheumatoid arthritis (RA) is a complex autoimmune disease with a significant genetic component.
• Cytotoxic T-lymphocyte antigen 4 (CTLA4) plays a crucial role in T-cell regulation and immune tolerance.
• Polymorphisms in the CTLA4 gene have been implicated in various autoimmune conditions.

Purpose of the Study:

• To investigate the association between CTLA4 gene polymorphisms (-318 C/T and 49 A/G) and rheumatoid arthritis in a Spanish population.
• To explore potential gender-specific and HLA-DRB1-associated effects of CTLA4 polymorphisms in RA.

Main Methods:

• Genotyping of CTLA4 -318 (C/T) and 49 (A/G) polymorphisms in 138 Spanish RA patients and 305 healthy controls.
• Allelic and genotypic frequency analysis, including stratification by gender and HLA-DRB1 status.
• Statistical analysis using P-values and odds ratios (OR) to determine significant associations.

Main Results:

• No significant differences in CTLA4 -318 polymorphism frequencies were observed between RA patients and controls.
• A significant increase in CTLA4 49 A/G heterozygous individuals was found in female RA patients compared to female controls (P=0.008, OR=2.0).
• Increased CTLA4 49 A/G heterozygosity was also observed in RA patients positive for HLA-DR3 compared to HLA-DR3-negative patients (P=0.009, OR=4.0), particularly in females.

Conclusions:

• The CTLA4 49 A/G polymorphism is associated with rheumatoid arthritis, especially in females and individuals carrying the HLA-DR3 allele.
• These findings suggest that CTLA4 gene variations may contribute to the pathogenesis of rheumatoid arthritis.
• The study provides further insight into the complex genetic underpinnings of RA.